Hepatitis B surface antigen (HBsAg) prevalence in China
China: Hepatitis B surface antigen (HBsAg) prevalence was 0.1% in 2024. βΌ Falling
Latest (2024)
0.1%
Change on year
unchanged
World rank
101st
of 194 countries
All-time high
0.2%
in 2015
All-time low
0.1%
in 2019
Years of data
10
2015β2024
Hepatitis B surface antigen (HBsAg) prevalence in China, 2015β2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hepatitis b surface antigen (hbsag) prevalence in China stood at 0.1%. That is the lowest value across all 10 years on record.
That represents a change of down 50.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in China peaked at 0.2% in 2015 and was at its lowest, 0.1%, in 2019.
That places China 101st out of 194 countries with data for 2024, putting it in the middle of the range.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.2% | 0.1% | 0.2% | 5 |
| 2020s | 0.1% | 0.1% | 0.1% | 5 |
Countries ranked near China
- 101 Singapore 0.1% compare
- 101 Serbia 0.1% compare
- 101 Thailand 0.1% compare
- 101 Trinidad and Tobago 0.1% compare
- 101 Tunisia 0.1% compare
- 101 Ukraine 0.1% compare
- 101 Uzbekistan 0.1% compare
- 101 Albania 0.1% compare
- 101 Armenia 0.1% compare
- 101 Australia 0.1% compare
- 101 Belize 0.1% compare
- 101 Bolivia, Plurinational State of 0.1% compare
- 101 Bhutan 0.1% compare
- 101 Denmark 0.1% compare
- 101 Dominican Republic 0.1% compare
- 101 Algeria 0.1% compare
- 101 Gambia 0.1% compare
- 101 Guyana 0.1% compare
- 101 Hungary 0.1% compare
- 101 Israel 0.1% compare
- 101 Jordan 0.1% compare
- 101 Kyrgyzstan 0.1% compare
- 101 Lebanon 0.1% compare
- 101 Lithuania 0.1% compare
- 101 Malaysia 0.1% compare
- 101 Oman 0.1% compare
- 101 Peru 0.1% compare
- 101 Paraguay 0.1% compare
- 101 Romania 0.1% compare
- 101 Russian Federation 0.1% compare
More health data for China
- Un projection of annual infant deaths, annual growth rate -1.15 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0985 % change on previous year (2090)
- Heat deaths vs projected death rates 2,029 (2090)
- Un projection of annual infant deaths 4,642 (2100)
- Population ages 65 and above, total, annual growth rate 1.51 % change on previous year (2025)
- Population ages 65 and above, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, total, per capita 0.1491 units per person (2025)
- Population, female, annual growth rate -0.0988 % change on previous year (2025)
- Population, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population, female, per capita 0.4909 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in China?
- Hepatitis b surface antigen (hbsag) prevalence in China was 0.1% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in China?
- The highest recorded value was 0.2% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in China?
- The lowest recorded value was 0.1% in 2019.
- How does China rank for hepatitis b surface antigen (hbsag) prevalence?
- China ranks 101st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in China?
- Over the last ten years it is down 50.0%. The long-run trend across the full record is falling.
- Where does this China data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV Β· JSON β 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).